Qi, W., Cooke, L. S., Stejskal, A., Riley, C., Croce, K. D., Saldanha, J. W., . . . Mahadevan, D. (2009). MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer. BioMed Central.

Qi, Wenqing, Larry S. Cooke, Amy Stejskal, Christopher Riley, Kimiko Della Croce, Jose W. Saldanha, David Bearss, and Daruka Mahadevan. MP470, a Novel Receptor Tyrosine Kinase Inhibitor, in Combination With Erlotinib Inhibits the HER Family/PI3K/Akt Pathway and Tumor Growth in Prostate Cancer. BioMed Central, 2009.

Qi, Wenqing, et al. MP470, a Novel Receptor Tyrosine Kinase Inhibitor, in Combination With Erlotinib Inhibits the HER Family/PI3K/Akt Pathway and Tumor Growth in Prostate Cancer. BioMed Central, 2009.